With respect to the tumor subtype, most tumors were luminal B (44.9%) or luminal A (22.4%), followed by HER2+ and triple-negative tumors (10.2% each) (Table 1; Additional Table 1). The gene discussed is ERBB2; the disease is neoplasm.